‘And if he comes?’ one of the characters asks the other near the end of Samuel Beckett’s play «Waiting for Godot». ‘We’ll be saved’, the other replies, although the nature of that salvation remains undefined. Waiting for something that may never happen is a risk of financing social innovation. But it is also a way to feed social change and transformation, often radical.
Supporting the testing and scaling of innovative solutions to tackle societal challenges is a long-term investment for which patient capital is needed. Patient capital can be considered a social investment instrument sited between traditional venture capital and traditional philanthropy. It can be used to support innovative entrepreneurs and startups with the goal of maximising social, rather than financial, returns. Are social investors willing to forgo financial returns and wait for maximum social impact?
The participants will engage in the discussion on the following points:
1) Brief introduction to the financing of testing and scaling social innovation.
2) Case presentation: Casa do Impacto- SCML’s Social investment Fund.
3) Discussion on the balance between financial return and social impact and the alliances needed between the different stakeholders.
Session format: Roundabout
If you’re already registered, save your seat this session: